Hugh McMillan
Professor, Department of Pediatrics, University of Ottawa
Pediatric Neurologist and Neuromuscular specialist at the Children’s Hospital of Eastern Ontario
Email HughDr. McMillan is a Pediatric Neurologist with specialization in Clinical Neurophysiology and Neuromuscular medicine at the Children’s Hospital of Eastern Ontario. He is a Professor in the Department of Pediatrics, Faculty of Medicine at the University of Ottawa. He holds a Clinical Research Chair (Level 2) at the University of Ottawa and is a Clinical Investigator at the CHEO Research Institute
He has been an author of over 125 publications in peer-review journals and was a co-editor of a Pediatric Electromyography textbook. He is also a leader in clinical and translational research in pediatric neurology & neuromuscular medicine.
Dr. McMillan completed a Neuromuscular and Neurophysiology Fellowship at Boston Children’s Hospital, Harvard University and the Lahey Clinic, Tufts University; a Pediatric Neurology Residency at the Children’s Hospital of Eastern Ontario, University of Ottawa and a Pediatric Residency at McMaster Children’s Hospital, McMaster University.

Read more about Hugh
Recent publications
Schiava, M, Dang, UJ, Wood, C, Wong, SC, Ward, LM, Lofra, RM et al.. Height, weight, and body mass index trajectories and their correlation with functional outcome assessments in boys with Duchenne muscular dystrophy. Dev Med Child Neurol. 2025. PMID:40887311
De Ford, C, Guridi, M, Chen, Y, Murphy, AP, Wood, C, McMillan, HJ et al.. Exploring the natural history of bone mineral density in Duchenne muscular dystrophy: a systematic literature review. Osteoporos Int. 2025. PMID:40879743
Ippolito, C, Deguise, MO, Lochmüller, H, McMillan, HJ, McAdam, L. Bullying experiences of youth with neuromuscular disorders and their well-being: A survey study. J Neuromuscul Dis. 2025. 22143602251369279 PMID:40853190
Grant, A, Smith, IC, Lessard, LER, Osman, H, Lochmuller, H, McMillan, HJ et al.. Financial Toxicity and Its Determinants in Individuals Living With Inherited and Acquired Neuromuscular Disorders: The BIND Study. Neurology. 2025.105 (5)e213982 PMID:40834345
Eisenkölbl, A, Lochmüller, H, Carter, MT, Hamilton, LE, McMillan, HJ. Congenital-onset MLASA2 from a novel YARS2 variant: A literature review. J Neuromuscul Dis. 2025. 22143602251369227 PMID:40808490
Pace, A, Roda, W, Poon, C, McMillan, HJ, Oskoui, M, MacKenzie, A et al.. A cost-utility analysis of newborn screening for spinal muscular atrophy in Canada. Orphanet J Rare Dis. 2025.20 (1)428 PMID:40804727
Smith, IC, Abusetah, Y, Osman, H, Garg, A, Grant, A, Lochmuller, H et al.. Assessing the socio-economic burden of inherited and inflammatory neuromuscular diseases (BIND study): a study protocol. Orphanet J Rare Dis. 2025.20 (1)404 PMID:40770363
Mackley, MP, Richer, J, Guerin, A, Caluseriu, O, Armstrong, L, Blood, KA et al.. Mainstreaming of clinical genetic testing: A conceptual framework. Genet Med. 2025.27 (8)101465 PMID:40417744
Pace, AC, Poon, C, Chakraborty, P, Oskoui, M, McMillan, H, Mackenzie, A et al.. Systematic review for economic evaluations on newborn screening for spinal muscular atrophy. J Neuromuscul Dis. 2025.12 (5)619-629 PMID:40400315
Gauvreau, G, Behlim, T, Ng, P, Hodgkinson, V, Selby, K, Mah, JK et al.. Respiratory and Bulbar Support in Spinal Muscular Atrophy Type I Treated with Nusinersen. Can J Neurol Sci. 2025. 1-8 PMID:40357918
See more on PubMed